Company: ZDAN
Filing Date: 2025-07-28
Form Type: F-1/A
Source: 0001683168-25-005450
Chunk: 112

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-07-28
Form: F-1/A
Chunk 112
---
 you must rely on a price appreciation of the Ordinary Shares for a return on your investment.

We currently intend to retain
most, if not all, of our available funds and any future earnings after this offering to fund the development and growth of our business.
As a result, we do not expect to pay any cash dividends in the foreseeable future. Therefore, you should not rely on an investment in
the Ordinary Shares as a source for any future dividend income.

| 58 |

A sale or perceived sale of a substantial number of our Ordinary Shares may cause the price of our Ordinary Shares to decline.

If our shareholders sell
substantial amounts of our Ordinary Shares in the public market, the market price of our Ordinary Shares could fall. Moreover, the perceived
risk of this potential dilution could cause shareholders to attempt to sell their shares and investors to short our Ordinary Shares.
These sales also make it more difficult for us to sell equity-related securities in the future at a time and price that we deem reasonable
or appropriate.

We may be subject to penny stock regulations and restrictions, and you may have difficulty selling our Ordinary Shares.

The SEC has adopted regulations
which generally define so-called “penny stocks” to be an equity security that has a market price of less than $5.00 per share
or an exercise price of less than $5.00 per share, subject to certain exemptions. If our Ordinary Shares become a “penny stock,”
we may become subject to Rule 15g-9 under the Exchange Act, or the “Penny Stock Rule.” This rule imposes additional sales
practice requirements on broker-dealers that sell such securities to persons other than established customers and “accredited investors”
(generally individuals with a net worth of $1,000,000 or annual incomes exceeding $200,000, or $300,000 together with their spouses).
For transactions covered by Rule 15g-9, a broker-dealer must make a special suitability determination for the purchaser’s written
consent to the transaction prior to sale. As a result, this rule may affect the ability of broker-dealers to sell our securities and
may affect the ability of purchasers to sell any of our securities to the secondary market.

For any transaction involving
a penny stock, unless exempt, the rules require delivery, prior to any transaction in a penny stock, of a disclosure schedule prepared
by the SEC relating to the penny stock market. Disclosure is also required to be made about sales commissions payable to both the broker-dealer